SARS-COV-2 WHOLE GENOME SEQUENCING

Laboratory: Sequencing and Bioinformatics

Test Description: SARS-CoV-2 lineage determination through Whole Genome Sequencing

This test is intended for reporting lineages of the SARS-CoV-2 virus that are considered by the Centers for Disease Control and Prevention and international public health community to be of the greatest public health interest and concern. These classifications were developed by the CDC, in collaboration with the SARS-CoV-2 Interagency Group (SIG) established by US Department of Health and Human Services (HHS), to describe variants with potential or evidence-based increased transmissibility, disease severity, interference with diagnostic test targets, decreased susceptibility to one or more therapies, and/or decreased neutralization by antibodies generated during infection or post-vaccination.

Order Approval Required? No

Specimen Type: Nasopharyngeal or Nose (Anterior Nares) swab in Viral Transport Media

Collection Container: 15 mL conical polypropylene tube

Optimal Volume: >/= 1 mL

Collection Guidelines:

DCLS approved submitters can request collection kits at DCLS_SSSKits@dgs.virginia.gov, if a DCLS test kit is available.

Storage Container: 15 mL conical polypropylene tube

Storage Instructions: Store specimens refrigerated at 2-8˚C for transfer to DCLS within 72 hours, specimens that cannot be transferred within this timeframe should be frozen at -70˚C and shipped on dry ice

Transportation Instructions:

Test Methodology: ARTIC cDNA enrichment and Illumina DNA Prep Library generation. Sequencing performed on Illumina MiSeq or NextSeq 550

Additional Information: Sequencing data generated by DCLS is for public health purposes and should not be used to independently to make decisions regarding the management of patient care

Causes For Rejection:

Possible Results: